Summit Securities Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,937
Closed -$128K 1309
2025
Q2
$128K Buy
+6,937
New +$123K 0.02% 327
2023
Q1
Sell
-300
Closed -$4K 1222
2022
Q4
$4K Sell
300
-200
-40% -$2.55K ﹤0.01% 1090
2022
Q3
$7K Buy
+500
New +$7.39K ﹤0.01% 815
2014
Q1
Sell
-73
Closed -$2K 551
2013
Q4
$2K Buy
+73
New +$1.88K ﹤0.01% 434

Other funds holding SBRA

Summit Securities Group's SBRA Position: Q3 2025 in Review

Summit Securities Group sold out of Sabra Healthcare REIT (SBRA) in Q3 2025, closing a stake of 6,937 shares — an estimated $128K sold.

Summit Securities Group first reported a position in SBRA in Q4 2013 and held it in 4 quarters. The position peaked at $128K in Q2 2025. 424 funds tracked by Wall St. Rank hold SBRA as of Q3 2025.

  • Summit Securities Group reported no remaining Sabra Healthcare REIT position as of Q3 2025 after selling out during the quarter.
  • Summit Securities Group sold 6,937 Sabra Healthcare REIT shares in Q3 2025, an estimated $128K.
  • Summit Securities Group first reported a position in Sabra Healthcare REIT in Q4 2013 and held it in 4 quarters.
  • Summit Securities Group's Sabra Healthcare REIT position peaked at $128K in Q2 2025.
  • 424 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2025.

Based on Summit Securities Group's 13F filing for Q3 2025, filed 13 Nov 2025.